Open AccessDrug Repurposing Screens Reveal FDA Approved Drugs Active Against SARS-CoV-2
Author(s) -
Mark Dittmar,
Jae Seung Lee,
Kanupriya Whig,
Elisha Segrist,
Minghua Li,
Kellie A. Jurado,
Kirandeep Samby,
Holly Ramage,
David M. Schultz,
Sara Cherry
Publication year - 2020
Publication title -
ssrn electronic journal
Language(s) - Uncategorized
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3678908
Subject(s) - vero cell , drug repositioning , cell culture , repurposing , pharmacology , viral entry , virology , drug , protease inhibitor (pharmacology) , coronavirus , tmprss2 , biology , medicine , virus , viral replication , covid-19 , viral load , ecology , genetics , disease , pathology , antiretroviral therapy , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom